The global autoinjectors market is expected to grow from USD 1.00 billion in 2020 to USD 4.58 billion by 2028, at a CAGR of 20.84% during the forecast period 2021-2028.
An autoinjector is a medicinal equipment intended to give a shot of a distinct medicine. The autoinjectors were originally created by considering the skepticism related to self-administration by drug delivery devices that are needle-based. Most of the autoinjectors are spring-loaded, disposable and one-use syringes. Autoinjectors are designed for self-treatment by patients or handling by inexperienced individuals. These are easy to use. The injection site is dependent on the loaded drug, but it is generally delivered into the buttocks or the thigh. Injectors are mainly triggered by merely thrusting the nozzle against the position of the needle. In specific devices, the protective cap is basic safety. Other devices utilize a protection mechanism related to nail guns. The injection is triggered by forcing the nozzle upon the needle's position and concurrently, while employing force, pushing a trigger switch at the rear point of the device. As autoinjectors comprise a hypodermic needle, it has the potential to create biohazard to waste management workers. Therefore, the protective cap is made to keep the needle sterilized and preserve the medication as well as offer sufficient sharps waste confinement after disposal.
This study delivers a comprehensive analysis of disease indications, end-uses and regions.The disease indication segment includesanaphylaxis, diabetes, multiple sclerosis and rheumatoid arthritis. The anaphylaxis segment held the highest share in 2020. The highest share of the segment is due to the increasing frequency of anaphylactic reactions because of the insect stings, latex, medications and food. Another contributing factor to the growth of the segment is the allergic conditions being more prevalent health concern in children.The end-use segment includes ambulatory surgical centers, hospitals & clinics and home care settings.The hospital segment held the highest share in 2020. It is due to a rise in the frequency of diseases related to multiple sclerosis and anaphylaxis. Also, multiple sclerosis is highly prevalent across the globe, which requires hospitalization. It majorly contributed to the growth of the segment.
The market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America.The Asia Pacific region is expected to show the highest share over the forecast period. The growth of the region is anticipated due to the rise in the frequency of anaphylaxis and diabetics in Singapore, Japan, China and India. Also, an increase in the number of type 1 diabetes in children & adolescents in the region is expected to propel the growth of the market.
Some of the notable players in the global autoinjectors market are Owen Mumford, Teva Pharmaceutical, Mylan N.V., Sanofi, Amgen, Biogen Idec, Pfizer, Inc. and Ypsomed.
This study forecasts revenue growth at global, regional, and country levels from 2021 to 2028. Fior Markets has segmented the market based on below-mentioned segments:
Global Autoinjectors Market Analysis And Forecast, By Disease Indication
Global Autoinjectors Market Analysis And Forecast, By End-Use
Global Autoinjectors Market Analysis And Forecast, By Regional Analysis
Report Description:
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Disease Indication
4.3.2. Market Attractiveness Analysis By End-Use
4.3.3. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Rising incidence of anaphylaxis
5.3. Restraints
5.3.1. Alternative drug delivery mode
5.4. Opportunities
5.4.1. Need to limit patient visits
6. Global Autoinjectors Market Analysis and Forecast, By Disease Indication
6.1. Segment Overview
6.2. Anaphylaxis
6.3. Diabetes
6.4. Multiple Sclerosis
6.5. Rheumatoid Arthritis
7. Global Autoinjectors MarketAnalysis and Forecast, By End-Use
7.1. Segment Overview
7.2. Ambulatory Surgical Centers
7.3. Hospitals & Clinics
7.4. Home Care Settings
8. Global Autoinjectors MarketAnalysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global Autoinjectors Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in Global Autoinjectors Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Product Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1. Owen Mumford
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Product Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. Teva Pharmaceutical
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Product Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. Mylan N.V.
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Product Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. Sanofi
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Product Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. Amgen
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Product Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. Biogen Idec
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Product Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. Pfizer, Inc.
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Product Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
10.8. Ypsomed
10.8.1. Business Overview
10.8.2. Company Snapshot
10.8.3. Company Market Share Analysis
10.8.4. Company Product Portfolio
10.8.5. Recent Developments
10.8.6. SWOT Analysis
List of Table
1. Global Autoinjectors Market, By Disease Indication, 2018-2028(USD Billion)
2. GlobalAnaphylaxis, AutoinjectorsMarket, By Region, 2018-2028(USD Billion)
3. GlobalDiabetes, Autoinjectors Market, By Region, 2018-2028(USD Billion)
4. Global Autoinjectors Market, ByEnd-Use, 2018-2028(USD Billion)
5. GlobalAmbulatory Surgical Centers, Autoinjectors Market, By Region, 2018-2028(USD Billion)
6. Global Hospitals & Clinics, Autoinjectors Market, By Region, 2018-2028(USD Billion)
7. Global Home Care Settings, Autoinjectors Market, By Region, 2018-2028 (USD Billion)
8. North America Autoinjectors Market, By Disease Indication, 2018-2028(USD Billion)
9. North America Autoinjectors Market, ByEnd-Use, 2018-2028(USD Billion)
10. U.S. Autoinjectors Market, By Disease Indication, 2018-2028(USD Billion)
11. U.S. Autoinjectors Market, By End-Use, 2018-2028(USD Billion)
12. Canada Autoinjectors Market, By Disease Indication, 2018-2028(USD Billion)
13. CanadaAutoinjectors Market, By End-Use, 2018-2028(USD Billion)
14. Mexico Autoinjectors Market, By Disease Indication, 2018-2028(USD Billion)
15. Mexico Autoinjectors Market, By End-Use, 2018-2028(USD Billion)
16. Europe Autoinjectors Market, By Disease Indication, 2018-2028(USD Billion)
17. Europe Autoinjectors Market, By End-Use, 2018-2028(USD Billion)
18. Germany Autoinjectors Market, By Disease Indication, 2018-2028(USD Billion)
19. Germany Autoinjectors Market, By End-Use, 2018-2028(USD Billion)
20. France Autoinjectors Market, By Disease Indication, 2018-2028(USD Billion)
21. France Autoinjectors Market, By End-Use, 2018-2028(USD Billion)
22. U.K. Autoinjectors Market, By Disease Indication, 2018-2028(USD Billion)
23. U.K. Autoinjectors Market, By End-Use, 2018-2028(USD Billion)
24. Italy Autoinjectors Market, By Disease Indication, 2018-2028(USD Billion)
25. Italy Autoinjectors Market, By End-Use, 2018-2028(USD Billion)
26. Spain Autoinjectors Market, By Disease Indication, 2018-2028(USD Billion)
27. Spain Autoinjectors Market, By End-Use, 2018-2028(USD Billion)
28. Asia Pacific Autoinjectors Market, By Disease Indication, 2018-2028(USD Billion)
29. Asia Pacific Autoinjectors Market, By End-Use, 2018-2028(USD Billion)
30. Japan Autoinjectors Market, By Disease Indication, 2018-2028(USD Billion)
31. Japan Autoinjectors Market, By End-Use, 2018-2028(USD Billion)
32. China Autoinjectors Market, By Disease Indication, 2018-2028(USD Billion)
33. China Autoinjectors Market, By End-Use, 2018-2028(USD Billion)
34. India Autoinjectors Market, By Disease Indication, 2018-2028(USD Billion)
35. India Autoinjectors Market, By End-Use, 2018-2028(USD Billion)
36. South America Autoinjectors Market, By Disease Indication, 2018-2028(USD Billion)
37. South America Autoinjectors Market, By End-Use, 2018-2028(USD Billion)
38. Brazil Autoinjectors Market, By Disease Indication, 2018-2028(USD Billion)
39. Brazil Autoinjectors Market, By End-Use, 2018-2028(USD Billion)
40. Middle East and Africa Autoinjectors Market, By Disease Indication, 2018-2028(USD Billion)
41. Middle East and Africa Autoinjectors Market, By End-Use, 2018-2028(USD Billion)
42. UAE AutoinjectorsMarket, By Disease Indication, 2018-2028(USD Billion)
43. UAE Autoinjectors Market, By End-Use, 2018-2028(USD Billion)
44. South Africa Autoinjectors Market, By Disease Indication, 2018-2028(USD Billion)
45. South Africa Autoinjectors Market, By End-Use, 2018-2028(USD Billion)
List of Figures
1. Global Autoinjectors MarketSegmentation
2. Global Autoinjectors Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Autoinjectors Market Attractiveness Analysis By Disease Indication
9. Global Autoinjectors Market Attractiveness Analysis By End-Use
10. Global Autoinjectors Market Attractiveness Analysis By Region
11. Global Autoinjectors Market: Dynamics
12. Global Autoinjectors Market Share by Disease Indication(2021&2028)
13. Global Autoinjectors Market Share by End-Use (2021&2028)
14. Global Autoinjectors Market Share by Regions (2021&2028)
15. Global Autoinjectors Market Share by Company (2020)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.